Hepatitis C Virus Clearance by Direct-Acting Antivirals Agents Improves Endothelial Dysfunction and Subclinical Atherosclerosis: HEPCAR Study

• Published in: Clinical and translational gastroenterology Vol. 11; no. 8; p. e00203
• Main Authors: Muñoz-Hernández, Rocío, Ampuero, Javier, Millán, Raquel, Gil-Gómez, Antonio, Rojas, Ángela, Macher, Hada C., Gallego-Durán, Rocío, Gato, Sheila, Montero-Vallejo, Rocío, Rico, María C., Maya-Miles, Douglas, Sánchez-Torrijos, Yolanda, Soria, Isabel Carmona, Stiefel, Pablo, Romero-Gómez, Manuel
• Format: Journal Article
• Language: English
• Published: United States Wolters Kluwer 01.08.2020; Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins
• Subjects: Atherosclerosis; Biomarkers; Blood platelets; Cardiovascular disease; Cholesterol; Heart attacks; Hepatitis C; Hypertension; Infections; Inflammation; Insulin resistance; Lipoproteins; Liver; Liver cancer; Liver diseases; Metabolism; Normal distribution; Oxidative stress; Risk factors; Software; Vascular endothelial growth factor; Viral infections

Hepatitis C virus (HCV) infection has been related to increased cardiovascular (CV) risk. The aim of this study was to analyze the impact of sustained virological response (SVR) on endothelial dysfunction and subclinical atherosclerosis in patients with hepatitis C virus treated with direct-acting a...